Ahead of a special (MIS)Treated Live, Nam Kiwanuka speaks with Wendy Wolfman MD,FRCS(C), FACOG, NCMP a menopause pioneer in Canada and internationally recognized expert about how that study shaped decades of care, and what we understand now
Fainting may be more common during the initial stages of semaglutide treatment as your body adjusts to the medication
If you feel ignored, ask for a short visit just to go over your logs and medication plan
There is also emerging research for Akkermansias ability to reduce the prevalence of prediabetes, stimulate GLP-1 production, regulate liver enzyme activity, and diversify the gut microbiome through supplementation, highlighting its immense range of promising potential applications
GLP-1 receptor agonists work by meticulously mimicking the natural incretin hormones your gut produces after eating